TY - JOUR T1 - Majeed Syndrome: Five Cases With Novel Mutations From Unrelated Families in India With a Review of Literature JF - The Journal of Rheumatology JO - J Rheumatol DO - 10.3899/jrheum.201663 SP - jrheum.201663 AU - Pallavi Pimpale Chavan AU - Ivona Aksentijevich AU - Aditya Daftary AU - Hiren Panwala AU - Chetna Khemani AU - Archana Khan AU - Raju Khubchandani Y1 - 2021/05/15 UR - http://www.jrheum.org/content/early/2021/08/11/jrheum.201663.abstract N2 - Objective Majeed syndrome (MJS) is an autosomal recessive, systemic autoinflammatory disease (SAID) caused by biallelic loss-of-function variants in the LPIN2 gene. It is characterized by early-onset chronic recurrent multifocal osteomyelitis (CRMO), dyserythropoietic anemia, and neutrophilic dermatosis. We analyzed a cohort of uncharacterized Indian patients for pathogenic variants in LPIN2 and other genes associated with SAIDs. Methods We performed whole-exome sequencing (WES) for 1 patient and next-generation sequencing (NGS) targeted gene panel for SAIDs in 3 patients. One patient was a referral from neurology after clinical exome sequencing identified a novel variant in LPIN2. We reviewed the literature for all published studies of mutation-positive MJS patients and have summarized their clinical features and disease-causing variants. Results We describe the largest series of patients with MJS outside of the Middle East. All 5 patients are homozygous for novel, possibly pathogenic variants in the LPIN2 gene. Two of these variants are missense substitutions, and 3 are predicted to alter transcript splicing and create a truncated protein. In addition to the classical features of CRMO and anemia, patients exhibited previously unreported features, including abdominal pain, recurrent diarrhea/ear discharge, and erythema nodosum. Conclusion Patients with MJS may present initially to different specialists, and thus it is important to create awareness in the medical community. In India, consanguinity is a common sociocultural factor in many ethnic communities and an abbreviated NGS gene panel for autoinflammatory diseases should include MJS. The unavailability of interleukin 1 inhibitors in some countries poses a treatment challenge. ER -